Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pediatric retinal vascular disorders: From translational sciences to clinical practice. | Saudi J Ophthalmol | 2023 | 38155677 | PubTator, text mining | PubMed |
Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology. | Cell Mol Neurobiol | 2023 | 38150042 | PubTator, text mining | PubMed |
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis. | Biomedicines | 2023 | 38137330 | PubTator, text mining | PubMed |
| Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia. | Animals (Basel) | 2023 | 38136788 | PubTator, text mining | PubMed |
| Engineered In Vitro Tumor Model Recapitulates Molecular Signatures of Invasion in Glioblastoma. | ACS Mater Au | 2023 | 38089093 | PubTator, text mining | PubMed |
| Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. | J Exp Clin Cancer Res | 2023 | 38087324 | PubTator, text mining | PubMed |
| The effects of semaphorin 3A in bone and cartilage metabolism: fundamental mechanism and clinical potential. | Front Cell Dev Biol | 2023 | 38078001 | PubTator, text mining | PubMed |
| Role of ADAM and ADAMTS proteases in pathological tissue remodeling. | Cell Death Discov | 2023 | 38071234 | PubTator, text mining | PubMed |
| Oral Pyogenic Granuloma: A Narrative Review. | Int J Mol Sci | 2023 | 38069207 | PubTator, text mining | PubMed |
| In silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus. | J Ayurveda Integr Med | 2023 | 38048723 | PubTator, text mining | PubMed |
| Structure guided mutagenesis of Henipavirus Receptor Binding Proteins reveals molecular determinants of receptor usage and antibody binding epitopes. | bioRxiv | 2023 | 38045373 | PubTator, text mining | PubMed |
| Targeting SIRT1 synergistically improves the antitumor effect of JQ-1 in hepatocellular carcinoma. | Heliyon | 2023 | 38045194 | PubTator, text mining | PubMed |
| Pangenomic and immunoinformatics based analysis of Nipah virus revealed CD4+ and CD8+ T-Cell epitopes as potential vaccine candidates. | Front Pharmacol | 2023 | 38035008 | PubTator, text mining | PubMed |
| The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern. | Front Endocrinol (Lausanne) | 2023 | 38027131 | PubTator, text mining | PubMed |
| A novel program of infiltrative control in astrocytomas: ADAM23 depletion promotes cell invasion by activating γ-secretase complex. | Neurooncol Adv | 2023 | 38024245 | PubTator, text mining | PubMed |
| Role of Pericytes in Cardiomyopathy-Associated Myocardial Infarction Revealed by Multiple Single-Cell Sequencing Analysis. | Biomedicines | 2023 | 38001896 | PubTator, text mining | PubMed |
| Revealing the potential of necroptosis-related genes in prognosis, immune characteristics, and treatment strategies for head and neck squamous cell carcinoma. | Sci Rep | 2023 | 37989855 | PubTator, text mining | PubMed |
| Endothelial progenitor cells in pregnancy-related diseases. | Clin Sci (Lond) | 2023 | 37986615 | PubTator, text mining | PubMed |
| A Massively Parallel Screen of 5'UTR Mutations Identifies Variants Impacting Translation and Protein Production in Neurodevelopmental Disorder Genes. | medRxiv | 2023 | 37961498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=11